<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28216632</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2017</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Resveratrol treatment reveals a novel role for HMGB1 in regulation of the type 1 interferon response in dengue virus infection.</ArticleTitle><Pagination><StartPage>42998</StartPage><MedlinePgn>42998</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">42998</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep42998</ELocationID><Abstract><AbstractText>Dengue is one of the most significant mosquito-borne virus diseases worldwide, particularly in tropical and subtropical regions. This study sought to examine the antiviral activity of resveratrol (RESV), a phytoalexin secreted naturally by plants, against dengue virus (DENV) infection. Our data showed that RESV inhibits the translocation of high mobility group box 1 (HMGB1), a DNA binding protein that normally resides in the nucleus, into the cytoplasm and extracellular milieu. HMGB1 migrates out of the nucleus during DENV infection. This migration is inhibited by RESV treatment and is mediated by induction of Sirt1 which leads to the retention of HMGB1 in the nucleus and consequently helps in the increased production of interferon-stimulated genes (ISGs). Nuclear HMGB1 was found to bind to the promoter region of the ISG and positively regulated the expression of ISG. The enhanced transcription of ISGs by nuclear HMGB1 thus contributes to the antiviral activity of RESV against DENV. To the best of our knowledge, this is the first report to demonstrate that RESV antagonizes DENV replication and that nuclear HMGB1 plays a role in regulating ISG production.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zainal</LastName><ForeName>Nurhafiza</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Graduate Studies, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chih-Peng</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yi-Lin</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yan-Wei</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Microbiology &amp;Immunology and Pediatrics, and Canadian Center for Vaccinology, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Shu-Wen</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chia-Ling</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Translational Research Center, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Tzong-Shiann</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, National Cheng Kung University Hospital, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AbuBakar</LastName><ForeName>Sazaly</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Graduate Studies, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tropical Infectious Diseases Research and Education Centre (TIDREC), University of Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yee-Shin</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024243">HMGB1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C579071">MX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064547">Myxovirus Resistance Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013267">Stilbenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.1.-</RegistryNumber><NameOfSubstance UI="D056564">Sirtuin 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q369O8926L</RegistryNumber><NameOfSubstance UI="D000077185">Resveratrol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024243" MajorTopicYN="N">HMGB1 Protein</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064547" MajorTopicYN="N">Myxovirus Resistance Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077185" MajorTopicYN="N">Resveratrol</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056564" MajorTopicYN="N">Sirtuin 1</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013267" MajorTopicYN="N">Stilbenes</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28216632</ArticleId><ArticleId IdType="pmc">PMC5316936</ArticleId><ArticleId IdType="doi">10.1038/srep42998</ArticleId><ArticleId IdType="pii">srep42998</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bhatt S. et al.. The global distribution and burden of dengue. Nature 496, 504&#x2013;507 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins J. W. et al.. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481&#x2013;485 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3409588</ArticleId><ArticleId IdType="pubmed">21478870</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao S. et al.. Structural basis of oligomerization in the stalk region of dynamin-like MxA. Nature 465, 502&#x2013;506 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20428112</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Collins M. N., Hsiang T. Y. &amp; Krug R. M. Interferon-induced ISG15 pathway: an ongoing virus-host battle. Trends Microbiol. 21, 181&#x2013;186 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3622817</ArticleId><ArticleId IdType="pubmed">23414970</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla Y. &amp; Singh R. Resveratrol and cellular mechanisms of cancer prevention. Ann. N Y Acad. Sci. 1215, 1&#x2013;8 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21261635</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L. et al.. Resveratrol inhibits enterovirus 71 replication and pro-inflammatory cytokine secretion in rhabdosarcoma cells through blocking IKKs/NF-&#x3ba;B signaling pathway. PLoS One 10, e0116879 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4333343</ArticleId><ArticleId IdType="pubmed">25692777</ArticleId></ArticleIdList></Reference><Reference><Citation>Abba Y., Hassim H., Hamzah H. &amp; Noordin M. M. Antiviral activity of resveratrol against human and animal viruses. Adv. Virol. 2015, 184241 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4676993</ArticleId><ArticleId IdType="pubmed">26693226</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamara A. T. et al.. Inhibition of influenza A virus replication by resveratrol. J. Infect. Dis. 191, 1719&#x2013;1729 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15838800</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X. H. et al.. Resveratrol Inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells. Inflammation 35, 1392&#x2013;1401 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22391746</ArticleId></ArticleIdList></Reference><Reference><Citation>Clouser C. L. et al.. Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine. Bioorg. Med. Chem. Lett. 22, 6642&#x2013;6646 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3482103</ArticleId><ArticleId IdType="pubmed">23010273</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W. et al.. Novel role of resveratrol: suppression of high-mobility group protein box 1 nucleocytoplasmic translocation by the upregulation of sirtuin 1 in sepsis-induced liver injury. Shock 42, 440&#x2013;447 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25004063</ArticleId></ArticleIdList></Reference><Reference><Citation>Moisy D. et al.. HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replication. J. Virol. 86, 9122&#x2013;9133 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3416134</ArticleId><ArticleId IdType="pubmed">22696656</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassetta L. et al.. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines. AIDS 23, 567&#x2013;577 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19194273</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Wang H., Czura C. J. &amp; Tracey K. J. The cytokine activity of HMGB1. J. Leukoc. Biol. 78, 1&#x2013;8 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15734795</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotze M. T. &amp; Tracey K. J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5, 331&#x2013;342 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15803152</ArticleId></ArticleIdList></Reference><Reference><Citation>Allonso D., V&#xe1;zquez S., Guzm&#xe1;n M. G. &amp; Mohana-Borges R. High mobility group box 1 protein as an auxiliary biomarker for dengue diagnosis. Am. J. Trop. Med. Hyg. 88, 506&#x2013;509 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3592532</ArticleId><ArticleId IdType="pubmed">23269659</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L. C., Yeh T. M., Wu H. N.. Lin Y. Y. &amp; Shyu H. W. Dengue virus infection induces passive release of high mobility group box 1 protein by epithelial cells. J. Infect. 56, 143&#x2013;150 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18076993</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamau E. et al.. Dengue virus infection promotes translocation of high mobility group box 1 protein from the nucleus to the cytosol in dendritic cells, upregulates cytokine production and modulates virus replication. J. Gen. Virol. 90, 1827&#x2013;1835 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19369409</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong S. P., Lee L. M., Leong Y. F., Ng M. L. &amp; Chu J. J. Dengue virus infection mediates HMGB1 release from monocytes involving PCAF acetylase complex and induces vascular leakage in endothelial cells. PLoS One 7, e41932 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3408393</ArticleId><ArticleId IdType="pubmed">22860034</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C., Wang Y., Dong L., Li M. &amp; Cai W. Anti-inflammatory effect of resveratrol through the suppression of NF-kappaB and JAK/STAT signaling pathways. Acta. Biochim. Biophys. Sin. (Shanghai) 47, 207&#x2013;213 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25651848</ArticleId></ArticleIdList></Reference><Reference><Citation>Howitz K. T. et al.. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191&#x2013;196 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12939617</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb S. &amp; Esposito R. E. A new role for a yeast transcriptional silencer gene, SIR2, in regulation of recombination in ribosomal DNA. Cell 56, 771&#x2013;776 (1989).</Citation><ArticleIdList><ArticleId IdType="pubmed">2647300</ArticleId></ArticleIdList></Reference><Reference><Citation>Brachmann C. B. et al.. The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes Dev. 9, 2888&#x2013;2902 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7498786</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukamoto Y., Kato J. &amp; Ikeda H. Silencing factors participate in DNA repair and recombination in Saccharomyces cerevisiae. Nature 388, 900&#x2013;903 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9278054</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao C. M. &amp; Haase V. H. Sirtuins and their relevance to the kidney. J. Am. Soc. Nephrol. 21, 1620&#x2013;1627 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4527176</ArticleId><ArticleId IdType="pubmed">20595677</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang J. S. et al.. Deacetylation-mediated interaction of SIRT1-HMGB1 improves survival in a mouse model of endotoxemia. Sci. Rep. 5, 15971 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4629154</ArticleId><ArticleId IdType="pubmed">26522327</ArticleId></ArticleIdList></Reference><Reference><Citation>Campagna M. &amp; Rivas C. Antiviral activity of resveratrol. Biochem. Soc. Trans. 38, 50&#x2013;53 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20074034</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller O., Staeheli P., Schwemmle M. &amp; Kochs G. Mx GTPases: dynamin-like antiviral machines of innate immunity. Trends Microbiol. 23, 154&#x2013;163 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25572883</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeg C. et al.. Transgenic mice carrying interferon-regulated human MxA locus are highly resistant to avian but not human influenza A viruses. Cytokine 63, 258 (2013).</Citation></Reference><Reference><Citation>Raychoudhuri A. et al.. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J. Virol. 85, 12881&#x2013;12889 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3233139</ArticleId><ArticleId IdType="pubmed">21976647</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D. et al.. Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J. Virol. 84, 8332&#x2013;8341 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916517</ArticleId><ArticleId IdType="pubmed">20534863</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T. et al.. Resveratrol, sirtuins, and viruses. Rev. Med. Virol. 25, 431&#x2013;445 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26479742</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder-Smith A. &amp; Gubler D. J. Dengue vaccines at a crossroad. Science 350, 626&#x2013;627 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26542552</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu M., Yu S., Xu W., Gao B. &amp; Xiong S. HMGB1 promotes systemic lupus erythematosus by enhancing macrophage inflammatory response. J. Immunol. Res. 2015, 946748 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4452473</ArticleId><ArticleId IdType="pubmed">26078984</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>